Transfer of interleukin-4 and interleukin-10 in patients with severe inflammatory bowel disease of the rectum

Human Gene Therapy

Volumn 11, Issue 12, 2000, Pages 1731-1741

  Rogy, Michael A ^a   Beinhauer, Brigitte G ^a   Reinisch, Walter ^a   Huang, Leaf ^a   Pokieser, Peter ^a  

^a University of Surgery   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; LIPOSOME; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL TRIAL; ENTERITIS; GENE THERAPY; GENE TRANSFER; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PATIENT SELECTION; RECTUM DISEASE; TH1 CELL; TH2 CELL;

CLINICAL TRIALS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; INTERLEUKIN-4; LIPOSOMES; PATIENT SELECTION; RECTAL DISEASES; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034632428     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050111386     Document Type: Article

References (50)

1. BAUMHOFER, J.M., GEISSLER, K., BEINHAUER, B., BRANDMEIER, H., WANG, J., LOSERT, U., PHILIP, R., AVERSA, G., and ROGY, M.A. (1998). Human IL-4 and IL-13 gene transfer in the mouse improves survival in lethal endotoxemia and ameliorates peritoneal macrophages immune competence. Eur. J. Immunol. 28, 610-615.
2. CAPLEN, N.J., ALTON, E.W.F.W., MIDDLETON, P.G., DORIN, J.R., STEVENSON, B.J., GAO, X., DURHAM, S.R., JEFFERY, P.K., HUDSON, M.E., and COUTELLE, C. (1995). Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1, 39-46.
3. DINARELLO, C.A., and WOLFF, S.M. (1993). The role of interleukin-1 in disease. N. Engl. J. Med. 328, 106-113.
4. DING, L., LINSLEY, P.S., HUANG, L.Y., GERMAIN, R.N., and SHEVACH, E.M. (1993). IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151, 1224-1234.
5. DOHERTY, T.M., SEDER, R.A., and SHER, A. (1996). Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156, 735-741.
6. DUCHMANN, R., KAISER, I., HERMANN, E., MAYET, W., EWE, K., and MEYER zum BUSCHFELDE, K.-H. (1995). Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol. 102, 448-455.
7. ELSON, C.O., SARTOR, R.B., TENNYSON, G.S., and RIDDELL, R.H. (1995). Experimental models of inflammatory bowel disease. Gastroenterology 109, 1344-1367.
8. FISHER, C.J., AGOSTI, J.M., OPAL, S.M., LOWRY, S.F., BALK, R.A., SADOFF, J.C., ABRAHAM, E., SCHEIN, R.M.H., and BENJAMIN, E. (1996). Treatment of septic shock with tumor necrosis factor receptor: Fc fusion protein. N. Engl. J. Med. 334, 1697-1702.
9. GAO, S., and HUANG, L. (1991). A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179, 280-285.
10. GAZZINELLI, R.T. (1996). Molecular and cellular basis of interleukin-12 activity in prophylaxis and therapy against infectious diseases. Mol. Med. Today 2(6), 258-267.
11. GILL, D.R., SOUTHERN, K.W., MOFFORD, K.A., SEDDON, T., HUANG, L., SORGI, F., THOMSON, A., MACVINISH, L.J., RATCLIFF, R., BILTON, D., LANE, D.J., LITTLEWOOD, J.M., WEBB, A.K., MIDDLETON, P.G., COLLEDGE, W.H., CUTHBERT, A.W., EVANS, M.J., HIGGINS, C.F., and HYDE, S.C. (1997). A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4, 199-209.
12. HUI, K.M., ANG, P.T., HUANG, L., and TAY, S.K. (1997). Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA-liposome complexes. Gene Ther. 4, 783-790.
13. ISNER, J.M., WALSH, K., SYMES, J., PIECZEK, A., TAKESHITA, S., LOWRY, J., ROSSOW, S., ROSENFIELD, K., WEIR, L., and BROGI, E. (1995). Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 91, 2687-2692.
14. KARTTUNNEN, R., BREESE, E.J., WALKER, S.J., and MACDONALD, T.T. (1994). Decreased mucosal interleukin-4 production in gut inflammation. J. Clin. Pathol. 47, 1015-1018.
15. KUCHARIZIK, T., STOLL, R., LÜGERING, N., and DOMSCHKE, W. (1995). Circulating anti-inflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 100, 452-456.
16. KUEHN, R., LÖEHLER, J., RENNICK, D., RAJEWSKY, K., and MUELLER, W. (1993). Interleukin-10 deficient mice develop chronic enterocolitis. Cell 75, 263-274.
17. LENSCHOW, D., BLUESTONE, J., and J.A. (1993). T cell co-stimulation and in vivo tolerance. Curr. Opin. Immunol. 5, 747-752.
18. McCABE, R.P., SECRIST, H., BOTNEY, M., EGAN, M., and PETERS, M.G. (1993). Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin. Immunol. Immunopathol. 66, 52-58.
19. McLACHLAN, G., DAVIDSON, D.J., STEVENSON, B.J., DICKINSON, P., DAVIDSON-SMITH, H., DORIN, J.R., and PORTEOUS, DJ. (1995). Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy. Gene Ther. 2, 614-622.
20. MORRIS, G.P., BECK, P.L., HERRIDGE, M.S., DEPEW, W.T., SZEWCZUK, M.R., and WALLACE, J.L. (1989). Hapten induced model of chronic inflammation and ulcération in the rat colon. Gastroenterology 96, 795-803.
21. MULLIN, G.E., VEZZA, F.R., and SAMPAT, A. (1993). Abnormal mRNA production in the intestinal mucosal lesions of inflammatory bowel disease. Gastroenterology 104, A751.
22. MURCH, S.H., BRAEGGER, C.P., WALKDER, S.J., and MAcDONALD, T.T. (1993). Location of tumour necrosis factor alpha by im-munohistochemistry in chronic inflammatory bowel disease. Gut 34, 1705-1709.
23. NABEL, E.G., GORDON, D., YANG, Z.Y., XU, L., SAN, H., PLAUTZ, G.E., WU, B.Y., GAO, X., HUANG, L., and NABEL, GJ. (1992). Gene transfer in vivo with DNA-liposome complexes: Lack of autoimmunity and gonadal localization. Hum. Gene Ther. 3, 649-656.
24. NABEL, G.J., NABEL, E.G., YANG, Z.Y., FOX, B.A., PLAUTZ, G.E., GAO, X., HUANG, L., SHU, S., GORDON, D., and CHANG, A.E. (1993). Direct gene transfer with DNA-liposome complexes in melanoma: Expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. U.S.A. 90, 11307-113011.
25. NEURATH, M.F., FUSS, I., KELSALL, B.L., PRESKY, D.H., WAEGELL, W., and STROBER, W. (1996). Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta mediated oral tolerance. J. Exp. Med. 183, 2605-2616.
26. NIESSNER, M., and VOLK, B.A. (1995). Altered Th1/Th2 cytokines profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reverse transcribed polymerase chain reaction (RT-PCR). Clin. Exp. Immunol. 101, 428-435.
27. ONDERDONK, A.B. (1995). The carrageenan model for experimental ulcerative colitis. Prog. Clin. Biol. Res. 186, 237-245.
28. PIRZER, U., SCHURMANN, G., POST, S., BETZLER, M., and MEUER, S.C. (1990). Differential responsiveness to CD3-Ti vs CD2-dependent activation of human intestinal T lymphocytes. Eur. J. Immunol. 20, 2339-2342.
29. QUIAO, L., BRAUNSTEIN, J., GOLLING, M., AUTSCHBACH, F., MOLLER, P., and MEUER, S. (1996). Differential regulation of human T cell responsiveness by mucosal versus blood monocytes. Eur. J. Immunol. 26, 922-927.
30. RADFORD-SMITH, G., McGOWAN, I., and JEWELL, D.P. (1994). Th1 and Th2 gene expression in inflammatory bowel disease. Gastroenterology 106, A757.
31. ROGY, M.A., AUFFENBERG, T., ESPAT, N.J., PHILIP, R., REMICK, D., WOLLENBERG, G.K., COPELAND, E.M., and MOLDAWER, L.L. (1996). Human tumor necrosis factor receptor (p55) and interleukin-10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J. Exp. Med. 181, 2289-2293.
32. RUGTVEIT, J., BAKKA, A., and BRANDZAEG, P. (1997a). Distribution of the B7.1 (CD80) and B7.2 (CD86) co-stimulatory molecules on subsets of antigen-presenting cells in human intestinal mucosa: Altered expression profiles associated with inflammatory bowel disease. Clin. Exp. Immunol. 110, 104-113.
33. RUGTVEIT, J., SCOTT, H., HALSTENSEN, T.S., NORSTEIN, J., and BRANDTZAEG, P. (1996). Expression of the Ll antigen (calprotectin) by tissue macrophages reflects recent recruitment from peripheral blood rather than up-regulation of local synthesis: implications for rejection diagnosis: in formalin-fixed kidney specimens. J. Pathol. 180, 194-199.
34. RUGTVEIT, J., HARALDSEN, G., HOGASEN, A.K., BAKKA, A., BRANDTZAEG, P., and SCOTT, H. (1995). Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+ L1 + monocyte-derived cells. Gut 37, 367-373.
35. RUGTVEIT, J., NILSEN, E.M., BAKKA, A., CARLSEN, H., BRANDTZAEG, P., and SCOTT, H. (1997b). Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 112, 1493-1505.
36. SARTOR, R.B. (1994). Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 106, 533-539.
37. SCHMID, R.M., WEIDENBACH, H., LIPTAY, S., and ADLER, G. (1997). Direct gene transfer into the colon using a double-balloon catheter. Endoscopy 29, 39-43.
38. SORNASSE, T., LARENAS, P.V., DAVIS, K.A., DE VRIES, J.E., and YSSEL, H. (1996). Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J. Exp. Med. 184, 473-483.
39. SPARWASSER, T., KOCH, E.S., VABULAS, R.M., HEEG, K., LIPFORD, G.B., ELLWART, J.W., and WAGNER, H. (1998). Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28, 2045-2054.
40. STROBER, W., and ERHARDT, R.O. (1993). Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice. Cell 75, 203-205.
41. TARGRAN, S.R., HANAUER, S.B., VAN DEVENTER, S.J., MAYER, L., PRESENT, D.H., BRAAKMAN, T., DeWOODY, K.L., SCHAIBLE, T.F., and RUTGEERTS, PJ. (1997). A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's disease cA2 study group. N. Engl. J. Med. 337, 1028-1035.
42. TERAMOTO, F., ROKUTAN, K., KAWAKAMFKY, Y., FUJIMURA, Y., UCHIDA, J., OKU, K., and YONEYAMA, M. (1996). Effect of 4G-beta-D-galactosylsucrose (lactosucrose) on fecal microflora in patients with chronic inflammatory bowel disease. J. Gastoenterol. 31, 33-42.
43. THOMPSON, C.B. (1995). Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81, 979-982.
44. VAN ZEE, K.J., MOLDAWER, L.L., OLDENBURG, H.S.A., THOMPSON, W.A., STACKPOLE, S.A., MONTEGUT, W.J., ROGY, M.A., MESCHTER, C., GALLATI, H., SCHILLER, C-D., RICHTER, W.F., LOETSCHER, H., ASHKENAZI, A., CHAMOW, S.M., WURM, F., GALVANO, S.E., LOWRY, S.F., and LESSLAUER, W. (1996). Protection against lethal E. coli bacteraemia in baboons (Papio anubis) by pretreatment with a 55 kDa TNF receptor (CD 120a)-immunoglobulin fusion protein RO 45-2081. J. Immunol. 156, 2221-2230.
45. DE WAAL MALEFYT, R., ABRAMS, J., BENNETT, B., FIGDOR, C., and DE VRIES, J.E. (1991a). IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174, 1209-1220.
46. DE WAAL MALEFYT, R., HAANEN, J.B.A.G., SPITS, H., RONCAROLO, M.G., TE VELDE, A., FIGDOR, C.G., JOHNSON, K., KASTELEIN, R., YSSEL, H., and DE VRIES, J.E. (1991b). IL-10 and viral IL-10 strongly reduce antigen specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II MHC expression. J. Exp. Med. 174, 915-924.
47. DE WAAL MALEFYT, R., YSSEL, H., and DE VRIES, J.E. (1993). Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. J. Immunol. 150, 4754-4765.
48. WESTBROOK, C.A., CHMURA, S.J., ARENAS, R.B., KIM, S.Y., and OTTO, G. (1994). Human APC gene expression in rodent colonic epithelium in vivo using liposomal gene delivery. Hum. Mol. Genet. 3, 2005-2010.
49. WILLEMS, F., MARCHANT, A., DELVILLE, J.P., GERARD, C., DELVAUX, A., VELU, T., DE BOE, R.M., and GOLDMAN, M. (1994). Interleukin-10 inhibits B7 and intercellular adhesion molecule-l expression on human monocytes. Eur. J. Immunol. 24, 1007-1009.
50. YAMADA, T., MARSHALL, S., SPECIAN, R.D., and GRISHAM, M.B. (1991). A comparative analysis of two models of colitis in rats. Gastroenterology 102, 1524-1534.